|
|
|
1-10 employees
View all
|
|
Biotechnology
|
|
5270 California Ave, 300, Irvine, California 92617, US
|
|
EndoCyclic Therapeutics is a biopharmaceutical company engaged in the development of the first non-hormone therapeutic for endometriosis. Endometriosis afflicts over 10% of women worldwide and is the #1 cause of infertility and disability among women in the reproductive years. Despite the prevalence of this painful disease, endometriosis is considered the most overlooked women’s health issue due to the lack of effective treatment options. EndoCyclic Therapeutics' team of world-class physicians, scientists, government officials and pharma/biotech professionals are actively working together to bring a solution to the millions of women suffering from endometriosis and awareness to this important women’s health issue. For more information, please visit www.endocyclictherapeutics.com.
|
EndoCyclic Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used EndoCyclic Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact EndoCyclic Therapeutics customer service number in your country click here to find.
Tanya Petrossian is the CEO of EndoCyclic Therapeutics. To contact Tanya Petrossian email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.